Daratumumab and Pomalidomide in Previously Treated Patients With AL Amyloidosis

NCT04895917 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
27
Enrollment
OTHER
Sponsor class

Stopped low patient enrollment rate

Conditions

Interventions

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia